 |
|
Presence and Treatment of Vascular Risk Factors in Patients With Vascular Cognitive Impairment
Kenneth Rockwood, MD, FRCPC;
Erika Ebly, PhD;
Vladimir Hachinski, MD, FRCP, DScMed;
David Hogan, MD, FRCPC
Arch Neurol. 1997;54(1):33-39.
Abstract
Objective
To document the presence and treatment of selected vascular risk factors in patients with vascular cognitive impairment and elements affecting undertreatment of vascular risk factors.
Design
Secondary analysis of the Canadian Study of Health and Aging database, which is a national, representative, cross-sectional study of the epidemiologic distribution of dementia in elderly people in Canada.
Setting
Survey.
Patients
Institutionalized and community-dwelling elderly people.
Main Outcome Measures
Vascular risk factors, dementia diagnosed by standard methods, and medication use.
Results
Treatable vascular risk factors occurred significantly more often in patients with vascular cognitive impairment (with and without dementia) than in patients with probable Alzheimer disease or normal cognitive function. For example, 76% of patients with vascular dementia and 57% of those with vascular cognitive impairment without dementia had a history of stroke, compared with only 5% of those with probable Alzheimer disease and 7% of those with no cognitive loss. (For hypertension, the comparable figures are 55%, 48%, 24%, and 38%, respectively.) Potential undertreatment of vascular risk factors had little effect on mean control of vascular risk factors. For example, the mean (±SD) systolic blood pressure in those being treated was 144±26 mm Hg, compared with 142±25 mm Hg in those not receiving pharmacological treatment. In each group (treated vs untreated), the proportion of patients with a systolic blood pressure higher than 160 mm Hg was 20% and 16%, respectively. Potential undertreatment occurred most often in those with severe dementia and those living in nursing homes.
Conclusions
Vascular risk factors occurred more commonly in patients with vascular cognitive impairment compared with other patients, including those with other forms of dementia. When present, such risk factors were often treated pharmacologically, except in patients with severe dementia and those in long-term care institutions. Undertreatment does not, in general, result in worsened risk factor control.
Author Affiliations
From the Division of Geriatric Medicine, Dalhousie University, Halifax, Nova Scotia (Dr Rockwood); the Division of Geriatric Medicine, University of Calgary, Alberta (Drs Ebly and Hogan); and the Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario (Dr Hachinski).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Medication Undertreatment in Assisted Living Settings
Sloane et al.
Arch Intern Med 2004;164:2031-2037.
ABSTRACT
| FULL TEXT
Cognitive Impairment and Decline Are Associated with Carotid Artery Disease in Patients without Clinically Evident Cerebrovascular Disease
Johnston et al.
ANN INTERN MED 2004;140:237-247.
ABSTRACT
| FULL TEXT
Risk Factors for Mild Cognitive Impairment in the Cardiovascular Health Study Cognition Study: Part 2
Lopez et al.
Arch Neurol 2003;60:1394-1399.
ABSTRACT
| FULL TEXT
Antithrombotic drugs in secondary stroke prevention among a community dwelling older population
Landi et al.
J. Neurol. Neurosurg. Psychiatry 2003;74:1100-1104.
ABSTRACT
| FULL TEXT
Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer's disease
Liolitsa et al.
J. Neurol. Neurosurg. Psychiatry 2002;73:261-266.
ABSTRACT
| FULL TEXT
Is Mild Cognitive Impairment Prodromal for Vascular Dementia Like Alzheimer's Disease?
Meyer et al.
Stroke 2002;33:1981-1985.
ABSTRACT
| FULL TEXT
Previous and Incident Dementia as Risk Factors for Mortality in Stroke Patients
Barba et al.
Stroke 2002;33:1993-1998.
ABSTRACT
| FULL TEXT
Societal Costs of Vascular Cognitive Impairment in Older Adults
Rockwood et al.
Stroke 2002;33:1605-1609.
ABSTRACT
| FULL TEXT
Use of Lipid-Lowering Agents, Indication Bias, and the Risk of Dementia in Community-Dwelling Elderly People
Rockwood et al.
Arch Neurol 2002;59:223-227.
ABSTRACT
| FULL TEXT
Preclinical syndromes predict dementia: the Sydney older persons study
Waite et al.
J. Neurol. Neurosurg. Psychiatry 2001;71:296-302.
ABSTRACT
| FULL TEXT
Clinical Correlates and Drug Treatment of Residents With Stroke in Long-Term Care Editorial Comment
Quilliam et al.
Stroke 2001;32:1385-1393.
ABSTRACT
| FULL TEXT
Incidence and outcomes of diabetes mellitus in elderly people: report from the Canadian Study of Health and Aging
Rockwood et al.
CMAJ 2000;162:769-772.
ABSTRACT
| FULL TEXT
Prevalence and outcomes of vascular cognitive impairment
Rockwood et al.
Neurology 2000;54:447-447.
ABSTRACT
| FULL TEXT
Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging
Maxwell et al.
CMAJ 1999;161:501-506.
ABSTRACT
| FULL TEXT
Association of Stroke With Dementia, Cognitive Impairment, and Functional Disability in the Very Old : A Population-Based Study
Zhu et al.
Stroke 1998;29:2094-2099.
ABSTRACT
| FULL TEXT
|
